We’re really disappointed to have to share our plans to postpone the International Antibody Validation Meeting scheduled for September this year.
Originally planned for autumn 2020, we took the difficult decision last year not to go ahead in light of the COVID-19 pandemic and restrictions on international travel. With no clarity as yet on what restrictions may still be in place by autumn 2021 we have decided that we will once again have to postpone the event.
Dr Andrew Chalmers, founder of CiteAb and one of the scientific organisers of the Meeting says: “We have given this a great deal of thought, and have explored a number of alternative ways to deliver the event digitally. However, we believe that the face-to-face interaction and the chance meetings that take place during our Antibody Validation events are extremely valuable to delegates and couldn’t be replicated satisfactorily in a digital space.
“We also host the event in the World Heritage City of Bath, which I know our delegates really love visiting and that this fantastic setting contributes to their overall enjoyment of the event. We want to host the event in a way that allows those attending to get the full experience.
“That said, while we are very much looking forward to delivering a live, in-person event in 2022, we have learnt a lot from the last year and will make elements of it available digitally to those unable to travel.”
CiteAb was born out of a need for researchers to find antibodies they knew would work in their research, and reduce waste of resources and time. In addition to being able to see where antibodies have been previously cited, having good validation procedures in place gives researchers confidence in the products they are purchasing.
Our whole team here at CiteAb is extremely passionate about antibody validation and we’re really looking forward to realising our fourth International Antibody Validation Meeting as soon as the global travel situation allows it.
Dr Chalmers adds: “I am extremely grateful to our sponsors and to our speakers who have been very supportive throughout this past year, and understanding of the changes we have had to make. They’re as excited about the event as we are, so I am sure that when we can finally meet we’ll be all treated to some fantastic content.”
The International Antibody Validation Meeting is a unique event organised by the University of Bath, with support from AstraZeneca and us here at CiteAb, which aims to bring together scientists from academia, the pharmaceutical/biotech sector and antibody suppliers in order to discuss best practices in research antibody validation and help improve antibody validation for the life science community.
Follow us on social media or keep an eye on our blog for updates – we’ll announce a new date for the Meeting as soon as we can!
– Rhys and the CiteAb team